Brenntag, the global market leader in chemical and ingredients distribution, today announced the appointment as distributor for Craft Health, Southeast Asia’s first and only 3D printing technology company offering customized solutions for drug delivery, with end-to-end solutions from research and development to manufacturing for the pharmaceuticals and nutraceuticals industries.

Craft Health’s 3D technology represents a leap forward in medical innovation, enabling the creation of personalized tablets that can be customized in terms of shape, dosage, and active ingredient delivery.

Romain Girard, Regional President, Pharma APAC, Brenntag Specialties, said, “Brenntag has a broad portfolio of world-class suppliers and value-added services, and our collaboration with Craft Health is highly compatible with our global Pharma strategy. This partnership is a game-changer for the pharmaceutical and complementary medicine segments, and I can’t wait to bring the transformative 3D technology to our customers, empowering them to deliver personalized treatments that enhance patient outcomes.”

"Craft Health is excited to collaborate with Brenntag in this groundbreaking partnership. By combining our expertise and optimizing synergies in automating mass customization using our proprietary 3D printing systems for pharmaceuticals and nutraceuticals with Brenntag's vast knowledge in chemical distribution and quality products, we aim to push the boundaries of innovation and bring transformative solutions to the healthcare industry," said Dr Wei Jiang GOH, CEO at Craft Health.